Clinical Trial

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Name: Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders — clinical trial record (NCT07261891)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: JAKarta

Recruiting

View on ClinicalTrials.gov →

Summary

The investigators want to study the JAK-inhibitors and their impact on the immune system and evaluate the potential of a gene-therapeutic strategy

Trial Details

NCT Number	NCT07261891
Lead Sponsor	prof. dr. Rik Schrijvers Collaborators: Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)
Conditions	Primary Immunodeficiency Diseases (PID)
Enrollment	20 participants
Start Date	2024-11-21
Primary Completion	2028-12-01 (estimated)
Study Completion	2030-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-03